Diagnostic Medical Systems (XPAR:ALDMS) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Diagnostic Medical Systems 5-Year EBITDA Growth Rate?

Diagnostic Medical Systems's EBITDA per Share for the six months ended in Jun. 2024 was €0.01.

During the past 12 months, Diagnostic Medical Systems's average EBITDA Per Share Growth Rate was -277.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -183.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Diagnostic Medical Systems was 77.90% per year. The lowest was -221.20% per year. And the median was -44.20% per year.

Competitive Comparison of Diagnostic Medical Systems's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Diagnostic Medical Systems's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnostic Medical Systems's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Diagnostic Medical Systems 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Diagnostic Medical Systems (XPAR:ALDMS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Diagnostic Medical Systems 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnostic Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (XPAR:ALDMS) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0RIA:UK DMS1:Germany

Address

9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660

Website

https://www.dms.com

Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines